Showing results (761-770 of 3,096) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|February 23, 2019
Management of residual masses in testicular germ cell tumorsAxel Heidenreich, Pia Paffenholz, Tim Nestler, et al.Expert Review of Anticancer Therapy|August 29, 2019
Advances in the therapy of BRAFV600E metastatic colorectal cancerZhaohui Jin, Frank A SinicropeExpert Review of Anticancer Therapy|August 27, 2019
What therapies are on the horizon for HER2 positive breast cancer?Giulia Viale, Stefania Morganti, Emanuela Ferraro, et al.Expert Review of Anticancer Therapy|September 13, 2019
Tumor heterogeneity: does it matter?Casmir Turnquist, Robert A Watson, Andrew Protheroe, et al.Expert Review of Anticancer Therapy|September 10, 2019
Controversies in locoregional management of breast cancer with low volume pN0(i+) and pN1mi nodal diseaseMaryam Dosani, Pauline T TruongExpert Review of Anticancer Therapy|January 6, 2022
Chemotherapy plus single/double immunotherapy in the treatment of non-oncogene addicted advanced non-small cell lung cancer: where do we stand and where are we going?Danilo Rocco, Luigi Della Gravara, Nicola Franzese, et al.Expert Review of Anticancer Therapy|December 14, 2021
Atezolizumab, cobimetinib, and vemurafenib as first-line treatment for unresectable metastatic BRAF V600 mutated melanomaAndreas M Schmitt, Lucy Dumas, James LarkinExpert Review of Anticancer Therapy|January 20, 2022
The RACE for children act at one year: progress in pediatric development of molecularly targeted oncology drugsMarjorie E ZettlerExpert Review of Anticancer Therapy|March 25, 2014
The benefit of chemotherapy in elderly patients with small cell lung cancerLaura C Caprario, Gary M StraussExpert Review of Anticancer Therapy|November 20, 2018
Defining the toxicity of current regimens for extranodal NK/T cell lymphoma: a systematic review and metaproportionVadim S Pokrovsky, Denis VinnikovPageof 310